Skip to content

Understanding Why do we start with F-75? in Severe Malnutrition Treatment

4 min read

According to the World Health Organization (WHO), severe acute malnutrition (SAM) affects millions of children globally, often with life-threatening medical complications. In these critical cases, treatment must follow a cautious, two-phased protocol, which directly explains why do we start with F-75? and not a more calorie-dense food.

Quick Summary

F-75 therapeutic milk is used in the initial stabilization phase for severe malnutrition to carefully restore metabolic function and treat complications. Its unique low-nutrient composition prevents refeeding syndrome, a dangerous condition caused by introducing high nutrition too quickly.

Key Points

  • Refeeding Syndrome Risk: Severe malnutrition puts the body in a fragile metabolic state; a rapid introduction of high-calorie food can cause dangerous and potentially fatal electrolyte shifts.

  • Stabilization First, Not Weight Gain: F-75 is designed for metabolic stabilization and correcting electrolyte imbalances, not for immediate weight gain.

  • Controlled Nutrient Intake: F-75's low energy, protein, and fat levels prevent overwhelming the patient's compromised system.

  • Phased Approach: Treatment for severe malnutrition is a multi-step process, with F-75 covering the initial stabilization phase and F-100 or RUTF used later for rehabilitation.

  • WHO-Endorsed Protocol: The World Health Organization's guidelines recommend the use of F-75 first to manage the acute medical complications associated with severe malnutrition.

  • Transition to Recovery: After the patient is stable and has a good appetite, they are carefully transitioned from F-75 to the higher-calorie F-100 to promote rapid catch-up growth.

In This Article

The Fragile Physiology of Severe Malnutrition

When a person, particularly a child, is suffering from severe acute malnutrition (SAM), their body's entire physiological state is compromised. It has adapted to a state of starvation, significantly slowing down its metabolism to conserve energy. This state of 'reductive adaptation' means that essential minerals and electrolytes within the body are severely depleted. When re-feeding begins, the introduction of carbohydrates and other nutrients triggers a rapid shift in metabolism. This sudden demand for already depleted electrolytes can lead to a dangerous and potentially fatal condition called refeeding syndrome.

The Dangers of Refeeding Syndrome

Refeeding syndrome is a critical and potentially lethal metabolic disturbance that can occur during the initial stages of nutritional rehabilitation. During this period, the patient's heart and lungs are especially vulnerable. The primary danger comes from rapid shifts in electrolytes, including phosphorus, potassium, and magnesium, which move from the bloodstream into the cells. The resulting deficiencies in the blood can cause a range of serious complications, including:

  • Heart arrhythmias or heart failure
  • Respiratory distress and muscle weakness
  • Seizures and neurological problems
  • Fluid retention and fluid overload

To prevent these severe and immediate risks, a highly controlled and slow-paced feeding process is essential. This is precisely the purpose of the initial stabilization phase of treatment, which uses F-75 therapeutic milk.

F-75: The Stabilizing Formula

F-75 therapeutic milk is specifically formulated to address the delicate metabolic state of a severely malnourished patient during the first phase of inpatient care. The “75” in its name refers to the 75 kilocalories it provides per 100ml, which is intentionally lower than standard formulas.

  • Low Energy Density: The modest energy level prevents the sudden metabolic shock that can trigger refeeding syndrome. It provides just enough energy to support basic metabolic functions without overwhelming the system.
  • Low Protein, Low Fat: F-75 contains very low levels of protein and fat, which are more difficult for a compromised system to process. This further minimizes metabolic strain during the stabilization period.
  • High Carbohydrate, Mineral-Rich: The formula is high in carbohydrates to provide readily available energy. Crucially, it is fortified with essential vitamins and minerals, specifically high levels of potassium and magnesium, to correct the severe electrolyte imbalances common in SAM.
  • Not for Weight Gain: The primary goal of F-75 is metabolic stabilization, not weight gain. The formula is designed to prepare the body for the next phase of treatment, not to rush the recovery process.

The Journey from F-75 to F-100

Transitioning a patient from the stabilization phase to the rehabilitation phase is a careful process guided by the World Health Organization protocols. Once the initial medical complications are under control and the patient has regained their appetite, they are ready for the next step. This is where the higher-calorie F-100 formula comes in. The following table highlights the differences between these two life-saving nutritional therapies:

Feature F-75 Therapeutic Milk F-100 Therapeutic Milk / RUTF
Phase of Treatment Stabilization Phase (Phase 1) Rehabilitation Phase (Phase 2)
Energy Density 75 kcal per 100 ml 100 kcal per 100 ml
Protein Content 0.9g per 100 ml 2.9g per 100 ml
Primary Purpose To correct electrolyte imbalances and stabilize metabolism To promote rapid weight gain and catch-up growth
Risks Low risk of refeeding syndrome Risk of refeeding syndrome if used prematurely
Patient Condition Medically complicated, may have poor appetite, fluid retention (oedema) Clinically stable, alert, has appetite, no major complications
Duration 2–7 days, depending on patient response Several weeks, transitioned to outpatient care

The Phased Approach: A Blueprint for Recovery

The WHO's 10-step process for managing severe acute malnutrition is divided into two main phases to ensure patient safety and effective recovery. This phased approach is critical because it directly addresses the unique needs of a severely compromised body.

  • Initial Stabilization Phase (with F-75):
    • Treat Hypoglycemia: Administer glucose/sucrose and begin feeding F-75.
    • Treat Hypothermia: Provide warmth and begin feeding.
    • Treat Dehydration: Administer special rehydration solution (ReSoMal) cautiously.
    • Correct Electrolyte Imbalance: F-75 is fortified with potassium and magnesium.
    • Treat Infection: Administer broad-spectrum antibiotics, as many patients have hidden infections.
    • Initiate Feeding: Begin with small, frequent feeds of F-75.
    • Address Micronutrient Deficiencies: Provide initial vitamin A and other supplements, but delay iron until later.
  • Rehabilitation Phase (with F-100/RUTF):
    • Introduce Catch-up Feeding: Gradually transition to F-100 or ready-to-use therapeutic food (RUTF) for weight gain.
    • Encourage Sensory Stimulation: Engage the patient to support psychological development.
    • Prepare for Follow-up: Plan for post-discharge care to prevent relapse.

The Critical First Step

The use of F-75 at the outset of severe malnutrition treatment is a testament to the meticulous science behind effective therapeutic nutrition. Rather than rushing to provide a high-calorie diet for rapid weight gain, the priority is to stabilize the patient's fragile metabolic state and correct dangerous electrolyte deficiencies. By understanding why we start with F-75, medical professionals can follow a protocol proven to safely restore a patient's health, paving the way for the robust nutritional recovery that follows with F-100. This two-step process has been pivotal in reducing child mortality rates from severe malnutrition across the globe.

Conclusion

In summary, the specific nutritional formulation of F-75, with its lower protein, fat, and energy content, is not an oversight but a deliberate strategy to prevent a fatal metabolic shock known as refeeding syndrome. It is the correct and medically sound first step in a carefully planned nutritional recovery process. This initial stabilization with F-75 ensures that the patient’s body is prepared to safely tolerate the higher-calorie, nutrient-dense F-100 formula that is introduced later for catch-up growth. This phased approach, endorsed by the WHO, is crucial for patient safety and maximizing the chances of a successful recovery from severe acute malnutrition.

Frequently Asked Questions

The low energy density and low protein content of F-75 are intentional to prevent refeeding syndrome, a dangerous metabolic complication. The formula is designed for stabilizing the patient's compromised system, not for immediate weight gain.

A patient is transitioned from F-75 to F-100 once their medical complications are stable, and they have regained their appetite. The transition is a gradual process over a few days to ensure tolerance.

Refeeding syndrome is a serious and real risk in severely malnourished patients. It can cause fatal heart and respiratory complications due to rapid and severe electrolyte shifts. Following a cautious feeding protocol like starting with F-75 is a necessary precaution.

While some recipes exist, commercial F-75 is highly recommended. It is difficult to replicate the precise nutrient and electrolyte balance, especially with a low-osmolarity profile, which is crucial for safety. Incorrect homemade formulas could cause complications like osmotic diarrhea.

No, F-75 does not contain iron. Iron is intentionally withheld during the initial stabilization phase because it can exacerbate existing infections in malnourished patients. Iron is only added later, during the rehabilitation phase with F-100 or RUTF.

The main difference is their purpose and composition. F-75 is a low-energy, low-protein formula for the initial stabilization phase. F-100 is a high-energy, high-protein formula for the rehabilitation phase, intended to support rapid weight gain.

The protocols for using F-75 and F-100 were developed based on recommendations and guidelines established by organizations like the World Health Organization (WHO) and pioneered by humanitarian organizations such as Action Against Hunger.

References

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11

Medical Disclaimer

This content is for informational purposes only and should not replace professional medical advice.